Showing 1,161 - 1,180 results of 29,602 for search '(( a web decrease ) OR ( 50 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.92s Refine Results
  1. 1161
  2. 1162
  3. 1163
  4. 1164
  5. 1165

    S2 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  6. 1166

    S1 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  7. 1167
  8. 1168
  9. 1169

    Heteroplasmy evolution of cybrid clone V_50. by Anton K. Raap (109844)

    Published 2012
    “…<p>(A) Average cellular mutation load decreases with increasing passage number of clone V_50. …”
  10. 1170

    Loneliness at 50+: The role of demographic and socioeconomic factors. by Sophie Guthmuller (9955408)

    Published 2022
    “…<p>Note: The figure displays odds ratios of individual socioeconomic and demographic variables at age 50+ for three different specifications. Specification (3) includes D, a set of individual socioeconomic and demographic variables at age 50+; P, a vector of the five scores of personality traits (extraversion, agreeableness, conscientiousness, neuroticism, openness); C, a vector of childhood circumstances (wealth; health; quality of the relationship with mother, father, and friends; importance of religion), and I, country-specific fixed effects. …”
  11. 1171
  12. 1172

    Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

    Published 2025
    “…We report the synthesis and characterization of 14 complexes of the type (Au(R)[N̂N])<sup>+</sup>, where R = tunable biaryldialkyl phosphine ligands and [N̂N] = bidentate phenanthroline derivatives as anticancer agents. …”
  13. 1173
  14. 1174
  15. 1175
  16. 1176
  17. 1177
  18. 1178
  19. 1179
  20. 1180